Bipolar Disorder Trial, Recruiting (NCT05153369)

Bipolar Disorder Trial, Recruiting NCT05153369 Sponsor: Centre for Addiction and Mental Health Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05153369 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be able to speak and understand English
You must be between 13 years old and 23 years and 11 months old
You have been diagnosed with bipolar disorder (BD) using a standard diagnostic interview, OR you have a biological parent or sibling who has been diagnosed with bipolar disorder type I or II
If you have bipolar disorder type I, you must currently be taking at least one mood-stabilizing medication (such as certain anti-seizure medications, antipsychotics, or lithium)
You are currently seeing a psychiatrist who regularly manages your care
You are willing and able to give your agreement to take part in the study (a parent or guardian may also need to give consent depending on your age)

Who may not be able to join:

People who have an intellectual disability, moderate to severe autism spectrum disorder, or a brain-related medical condition that would make it difficult to actively take part in the therapy sessions
People who currently have a serious, life-threatening medical condition that needs immediate treatment
People who are currently experiencing sexual or physical abuse
People who currently have a significant substance use problem (other than mild cannabis or alcohol use)
People who meet a certain level of assessed need (called "Level 3") at the time of enrollment (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benjamin I Goldstein, MD, PhD, Centre for Addiction and Mental Health

Phone: 416-535-8501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05153369

Sponsor: Centre for Addiction and Mental Health

Phase: Not Applicable

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: 416-535-8501

More information: https://clinicaltrials.gov/study/NCT05153369

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be able to speak and understand English
You must be between 13 years old and 23 years and 11 months old
You have been diagnosed with bipolar disorder (BD) using a standard diagnostic interview, OR you have a biological parent or sibling who has been diagnosed with bipolar disorder type I or II
If you have bipolar disorder type I, you must currently be taking at least one mood-stabilizing medication (such as certain anti-seizure medications, antipsychotics, or lithium)
You are currently seeing a psychiatrist who regularly manages your care
You are willing and able to give your agreement to take part in the study (a parent or guardian may also need to give consent depending on your age)

Who may not be able to join:

People who have an intellectual disability, moderate to severe autism spectrum disorder, or a brain-related medical condition that would make it difficult to actively take part in the therapy sessions
People who currently have a serious, life-threatening medical condition that needs immediate treatment
People who are currently experiencing sexual or physical abuse
People who currently have a significant substance use problem (other than mild cannabis or alcohol use)
People who meet a certain level of assessed need (called "Level 3") at the time of enrollment (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre for Addiction and Mental Health

Registry

ClinicalTrials.gov

Start date

1 November 2021

Est. completion

1 March 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder; Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder; Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder; Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder; Change in symptoms using the Mood and Feelings Questionnaire (MFQ); Change in symptoms using...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov